Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larissa Fabritz

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Cardiovascular Research|September 18, 2007
Drug-induced torsades de pointes--a form of mechano-electric feedback?Larissa Fabritz
Heart Rhythm|November 26, 2015
The power of P in the elderly: Small biphasic wave, big impactLarissa Fabritz
Journal of the American College of Cardiology|June 25, 2011
High-density lipoprotein shortens the ventricular action potential. A novel explanation for how statins prevent sudden arrhythmic death?Paulus Kirchhof, Larissa Fabritz
Cardiovascular Research|June 21, 2011
Can T-type calcium channels make a change of heart after myocardial infarction? Fiction or fact, and for better or for worse?Larissa Fabritz, Stefan Herzig
European Heart Journal|February 26, 2014
Of hammers and screws: renin-angiotensin-aldosterone system inhibition to prevent atrial fibrillation in patients with hypertensionPaulus Kirchhof, Larissa Fabritz
Heart (British Cardiac Society)|May 14, 2021
Heart failure in patients with atrial fibrillation: why it matters now more than everWinnie Chua, Larissa Fabritz
Lancet (London, England)|October 10, 2022
Artificial intelligence for early atrial fibrillation detectionLarissa Fabritz, Julius Obergassel
Lancet (London, England)|April 9, 2016
Can biomarkers balance stroke and bleeding risk?Paulus Kirchhof, Larissa Fabritz
Basic & Clinical Pharmacology & Toxicology|May 18, 2010
Predictable and less predictable unwanted cardiac drugs effects: individual pre-disposition and transient precipitating factorsLarissa Fabritz, Paulus Kirchhof
Heart Rhythm|February 16, 2012
Postrepolarization refractoriness: a mechanism in need for a molecule?Paulus Kirchhof, Larissa Fabritz
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Cardiovascular Research|September 18, 2007
Drug-induced torsades de pointes--a form of mechano-electric feedback?Larissa Fabritz
Heart Rhythm|November 26, 2015
The power of P in the elderly: Small biphasic wave, big impactLarissa Fabritz
Journal of the American College of Cardiology|June 25, 2011
High-density lipoprotein shortens the ventricular action potential. A novel explanation for how statins prevent sudden arrhythmic death?Paulus Kirchhof, Larissa Fabritz
Cardiovascular Research|June 21, 2011
Can T-type calcium channels make a change of heart after myocardial infarction? Fiction or fact, and for better or for worse?Larissa Fabritz, Stefan Herzig
European Heart Journal|February 26, 2014
Of hammers and screws: renin-angiotensin-aldosterone system inhibition to prevent atrial fibrillation in patients with hypertensionPaulus Kirchhof, Larissa Fabritz
Heart (British Cardiac Society)|May 14, 2021
Heart failure in patients with atrial fibrillation: why it matters now more than everWinnie Chua, Larissa Fabritz
Lancet (London, England)|October 10, 2022
Artificial intelligence for early atrial fibrillation detectionLarissa Fabritz, Julius Obergassel
Lancet (London, England)|April 9, 2016
Can biomarkers balance stroke and bleeding risk?Paulus Kirchhof, Larissa Fabritz
Basic & Clinical Pharmacology & Toxicology|May 18, 2010
Predictable and less predictable unwanted cardiac drugs effects: individual pre-disposition and transient precipitating factorsLarissa Fabritz, Paulus Kirchhof
Heart Rhythm|February 16, 2012
Postrepolarization refractoriness: a mechanism in need for a molecule?Paulus Kirchhof, Larissa Fabritz
Pageof 18